These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32627748)

  • 1. Proline/alanine-rich sequence (PAS) polypeptides as an alternative to PEG precipitants for protein crystallization.
    Schiefner A; Walser R; Gebauer M; Skerra A
    Acta Crystallogr F Struct Biol Commun; 2020 Jul; 76(Pt 7):320-325. PubMed ID: 32627748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient secretory production of proline/alanine/serine (PAS) biopolymers in Corynebacterium glutamicum yielding a monodisperse biological alternative to polyethylene glycol (PEG).
    Friedrich L; Kikuchi Y; Matsuda Y; Binder U; Skerra A
    Microb Cell Fact; 2022 Oct; 21(1):227. PubMed ID: 36307781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polypeptide biophysics of proline/alanine-rich sequences (PAS): Recombinant biopolymers with PEG-like properties.
    Breibeck J; Skerra A
    Biopolymers; 2018 Jan; 109(1):. PubMed ID: 29076532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins.
    Schlapschy M; Binder U; Börger C; Theobald I; Wachinger K; Kisling S; Haller D; Skerra A
    Protein Eng Des Sel; 2013 Aug; 26(8):489-501. PubMed ID: 23754528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of protein-precipitant interfaces and applied shear on the nucleation and growth of lysozyme crystals.
    Reis NM; Chirgadze DY; Blundell TL; Mackley MR
    Acta Crystallogr D Biol Crystallogr; 2009 Nov; 65(Pt 11):1127-39. PubMed ID: 19923710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A crystallization screen based on alternative polymeric precipitants.
    Grimm C; Chari A; Reuter K; Fischer U
    Acta Crystallogr D Biol Crystallogr; 2010 Jun; 66(Pt 6):685-97. PubMed ID: 20516621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects of PASylation® for the design of protein and peptide therapeutics with extended half-life and enhanced action.
    Gebauer M; Skerra A
    Bioorg Med Chem; 2018 Jun; 26(10):2882-2887. PubMed ID: 29102080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proline: Mother Nature's cryoprotectant applied to protein crystallography.
    Pemberton TA; Still BR; Christensen EM; Singh H; Srivastava D; Tanner JJ
    Acta Crystallogr D Biol Crystallogr; 2012 Aug; 68(Pt 8):1010-8. PubMed ID: 22868767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Doxorubicin Encapsulation and Pharmacokinetics of Ferritin-Fusion Protein Nanocarriers Bearing Proline, Serine, and Alanine Elements.
    Falvo E; Tremante E; Arcovito A; Papi M; Elad N; Boffi A; Morea V; Conti G; Toffoli G; Fracasso G; Giacomini P; Ceci P
    Biomacromolecules; 2016 Feb; 17(2):514-22. PubMed ID: 26686226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular recognition of structurally disordered Pro/Ala-rich sequences (PAS) by antibodies involves an Ala residue at the hot spot of the epitope.
    Schilz J; Binder U; Friedrich L; Gebauer M; Lutz C; Schlapschy M; Schiefner A; Skerra A
    J Mol Biol; 2021 Sep; 433(18):167113. PubMed ID: 34161780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defined PEG smears as an alternative approach to enhance the search for crystallization conditions and crystal-quality improvement in reduced screens.
    Chaikuad A; Knapp S; von Delft F
    Acta Crystallogr D Biol Crystallogr; 2015 Aug; 71(Pt 8):1627-39. PubMed ID: 26249344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancing protein crystallization through precipitant synergy.
    Majeed S; Ofek G; Belachew A; Huang CC; Zhou T; Kwong PD
    Structure; 2003 Sep; 11(9):1061-70. PubMed ID: 12962625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vapor diffusion, nucleation rates and the reservoir to crystallization volume ratio.
    Forsythe EL; Maxwell DL; Pusey M
    Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 1):1601-5. PubMed ID: 12351870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of salt concentration in PEG-based crystallization solutions.
    Yamanaka M; Inaka K; Furubayashi N; Matsushima M; Takahashi S; Tanaka H; Sano S; Sato M; Kobayashi T; Tanaka T
    J Synchrotron Radiat; 2011 Jan; 18(1):84-7. PubMed ID: 21169699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein Crystallization.
    McPherson A
    Methods Mol Biol; 2017; 1607():17-50. PubMed ID: 28573568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PASylation as a Powerful Technology for Improving the Pharmacokinetic Properties of Biopharmaceuticals.
    Ahmadpour S; Hosseinimehr SJ
    Curr Drug Deliv; 2018; 15(3):331-341. PubMed ID: 29165076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystallization, structure solution and refinement of hen egg-white lysozyme at pH 8.0 in the presence of MPD.
    Weiss MS; Palm GJ; Hilgenfeld R
    Acta Crystallogr D Biol Crystallogr; 2000 Aug; 56(Pt 8):952-8. PubMed ID: 10944331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein crystallization for X-ray crystallography.
    Dessau MA; Modis Y
    J Vis Exp; 2011 Jan; (47):. PubMed ID: 21304455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three commercial sparse-matrix crystallization screens.
    Wooh JW; Kidd RD; Martin JL; Kobe B
    Acta Crystallogr D Biol Crystallogr; 2003 Apr; 59(Pt 4):769-72. PubMed ID: 12657807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification, crystallization and preliminary crystallographic analysis of the periplasmic binding protein ProX from Escherichia coli.
    Breed J ; Kneip S ; Gade J ; Welte W ; Bremer E
    Acta Crystallogr D Biol Crystallogr; 2001 Mar; 57(Pt 3):448-50. PubMed ID: 11223528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.